- ►medicinainternacba.com.ar [PDF] - Free from Publisher H Sourij, R Zweiker, TC Wascher - Diabetes Care, 2006 - Am Diabetes Assoc OBJECTIVE—About one of five patients with coronary artery disease (CAD)
suffers from previously unknown, predominantly postprandial type 2 diabetes. In
the process of atherogenesis and the subsequent increased cardiovascular ... Cited by 38 - Related articles - BL Direct - All 8 versions
T Forst, G Lübben, C Hohberg, P Kann, C … - Microcirculation, 2005 - informahealthcare.com Results: HbA1c improved in both treatment arms (pioglitazone: 7.52 ± 0.85% to
6.71 ± 0.89%, p < .0001; glimepiride: 7.44 ± 0.89% to 6.83 ± 0.85%, p <
.0001). Insulin-resistance decreased significantly in the pioglitazone ... Cited by 32 - Related articles - BL Direct - All 6 versions
F Martens… - Journal of cardiovascular pharmacology, 2005 - journals.lww.com To determine whether pioglitazone influences endothelial function directly, we
examined in a randomized, crossover, placebo-controlled, double-blind trial the
effects of 4 weeks of pioglitazone treatment in 20 male type 2 diabetic ... Cited by 51 - Related articles - BL Direct - All 6 versions
T Forst, C Hohberg, SD Fuellert, G Lübben, T … - Hormone and metabolic research, 2005 - cat.inist.fr The role of intact proinsulin and adiponectin in endothelial dysfunction and
insulin resistance has been receiving increasing attention. This study
investigates the effect of PPARγ stimulation or beta-cell stimulation on ... Cited by 25 - Related articles - BL Direct - All 3 versions
- Free from Publisher K Nishio, M Sakurai, T Kusuyama, M … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—A total of 28 patients were randomly assigned to the control group,
and 26 patients were assigned to the pioglitazone group. There were no
significant differences in glycemic control levels or in lipid levels in ... Cited by 58 - Related articles - BL Direct - All 6 versions
T Horio, M Suzuki, I Takamisawa, K Suzuki, … - American Journal of Hypertension, 2005 - Elsevier Pioglitazone did not decrease fasting plasma glucose and hemoglobin A 1c (HbA 1c
) in the nondiabetic subjects, although the area under the curve for glucose and
insulin on OGTT significantly decreased. A marked decrease in SSPG was ... Cited by 19 - Related articles - All 4 versions
- ►ahajournals.org U Campia, LA Matuskey, JA Panza - Circulation, 2006 - Am Heart Assoc Methods and Results— The study had a randomized, double-blind,
placebo-controlled, crossover design. Eighty patients with either hypertension
or hypercholesterolemia were enrolled. Insulin sensitivity was assessed by ... Cited by 66 - Related articles - All 6 versions
- ►diabetesjournals.org K Esposito, M Ciotola, D Carleo, B Schisano, … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Compared with 60 control subjects matched for age and sex, patients
with the metabolic syndrome had decreased endothelial function, raised
concentrations of inflammatory markers, and reduced insulin sensitivity. ... Cited by 70 - Related articles - BL Direct - All 5 versions
G Derosa, AFG Cicero, A D'Angelo, A Gaddi, PD … - Hypertension Research, 2005 - nature.com The aim of our study was to compare the long-term effect of pioglitazone and
rosiglitazone on blood pressure control of diabetic patients with metabolic
syndrome treated with glimepiride. We evaluated 91 type 2 diabetic patients ... Cited by 36 - Related articles - BL Direct - All 5 versions
V Mattoo, D Eckland, M Widel, S Duran, C … - Clinical therapeutics, 2005 - Elsevier This was a 6-month, randomized, double-blind, prospective, multicenter,
placebo-controlled, parallel-group study. Patients with type 2 DM and a
glycosylated hemoglobin (HbA 1c ) value ≥7.5% who were using insulin ... Cited by 39 - Related articles - All 4 versions
